Although the precise role of Nrf2 in diabetes-related HTN remains controversial, numerous preclinical studies suggest that activation of Nrf2 signaling offers a promising strategy for amelioration of vascular OS and endothelial dysfunction during HTN. The gene discussed is NFE2L2; the disease is diabetes mellitus.